Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22005275 | 0.93 | CYP3A4 (0.41) | CYP3A4SMN1; SMN2ALDH1A1APPMAPT | |
| SCHEMBL28673732 | 0.92 | APP (0.46) | CYP3A4SMN1; SMN2ALDH1A1APPMAPT | |
| SCHEMBL24678322 | 0.88 | CYP3A4 (0.49) | CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL | |
| SCHEMBL28370253 | 0.88 | AHR (0.43) | SMN1; SMN2ALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL1818269 | 0.88 | AHR (0.43) | SMN1; SMN2ALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL15948906 | 0.88 | LMNA (0.44) | SMN1; SMN2ALDH1A1MAPTMTNR1AMTNR1B | |
| SCHEMBL719359 | 0.86 | ALDH1A1 (0.55) | CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL | |
| SCHEMBL25954061 | 0.85 | ELANE (0.46) | SMN1; SMN2ALDH1A1RECQLAPPMAPT | |
| SCHEMBL164160 | 0.85 | ELANE (0.46) | SMN1; SMN2ALDH1A1RECQLAPPMAPT | |
| SCHEMBL1817358 | 0.85 | SMN1; SMN2 (0.45) | CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3995493-B1 | CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE | TOKUYAMA CORP (JP) | 2024-07-03 | — | — | EP | disclosed |
| EP-2545095-B1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | TRANSITIONS OPTICAL INC (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20230280500-A1 | PHOTOCHROMIC COMPOUND, PHOTOCHROMIC CURABLE COMPOSITION, CURED BODY, LENS AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| US-20230242809-A1 | PHOTOCHROMIC HYDROXYURETHANE COMPOUND | TOKUYAMA CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230242809-A1 | PHOTOCHROMIC HYDROXYURETHANE COMPOUND | TOKUYAMA CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| EP-4047030-A1 | PHOTOCHROMIC HYDROXYURETHANE COMPOUND | Tokuyama Corporation (JP) | 2022-08-24 | — | — | EP | disclosed |
| US-20220213050-A1 | CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE | TOKUYAMA CORPORATION (JP) | 2022-07-07 | — | — | US | disclosed |
| EP-3995493-A1 | CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE | Tokuyama Corporation (JP) | 2022-05-11 | — | — | EP | disclosed |
| US-11066523-B2 | Photochromic polyrotaxane compound and curable composition comprising the photochromic polyrotaxane compound | TOKUYAMA CORPORATION (JP) | 2021-07-20 | — | — | US | disclosed |
| US-20200190106-A1 | CHROMENE COMPOUND, CURABLE COMPOSITION COMPRISING THE COMPOUND, AND OPTICAL ARTICLE INCLUDING A CURED BODY OF THE CURABLE COMPOSITION | TOKUYAMA CORPORATION (JP) | 2020-06-18 | — | — | US | disclosed |
| WO-2013078086-A1 | PHOTOCHROMIC COMPOUNDS HAVING AT LEAST TWO PHOTOCHROMIC MOIETIES | TRANSITIONS OPTICAL, INC. (US) | 2013-05-30 | — | — | WO | disclosed |
| EP-2545140-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES | Transitions Optical, Inc. (US) | 2013-01-16 | — | — | EP | disclosed |
| EP-2545095-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | Transitions Optical, Inc. (US) | 2013-01-16 | — | — | EP | disclosed |
| US-20120145973-A1 | Photochromic Materials That Include Indeno-Fused Naphthopyrans | TRANSITIONS OPTICAL INC. (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120136148-A1 | Photochromic Compounds Having At Least Two Photochromic Moieties | TRANSITIONS OPTICAL, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| WO-2011112327-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES | TRANSITIONS OPTICAL, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
| WO-2011112325-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | TRANSITIONS OPTICAL, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
| US-20110108781-A1 | PHOTOCHROMIC MATERIALS | TRANSITIONS OPTICAL, INC. (US) | 2011-05-12 | — | — | US | disclosed |
| US-20100221661-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES | TRANSITIONS OPTICAL, INC. (US) | 2010-09-02 | — | — | US | disclosed |
| US-20100209697-A1 | METHODS FOR PRODUCING PHOTOSENSITIVE MICROPARTICLES, NON-AQUEOUS DISPERSIONS THEREOF AND ARTICLES PREPARED THEREWITH | TRANSITIONS OPTICAL, INC. (US) | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213050-A1 | CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE | CRY1, CRY2, TRIP13 | CYP3A4 635/4885SMN1; SMN2 2698/4885NR1I2 144/4885 |
| US-20110108781-A1 | PHOTOCHROMIC MATERIALS | INCENP, SMCHD1, NEDD8 | CYP3A4 2934/4885SMN1; SMN2 4503/4885NR1I2 1201/4885 |
| US-20120145973-A1 | Photochromic Materials That Include Indeno-Fused Naphthopyrans | NQO1, INTS6, IPO4 | CYP3A4 249/4885SMN1; SMN2 4652/4885NR1I2 2932/4885 |
| US-20200190106-A1 | CHROMENE COMPOUND, CURABLE COMPOSITION COMPRISING THE COMPOUND, AND OPTICAL ARTICLE INCLUDING A CURED BODY OF THE CURABLE COMPOSITION | INCENP, SMCHD1, ILK | CYP3A4 1425/4885SMN1; SMN2 1968/4885NR1I2 1421/4885 |
| US-20120136148-A1 | Photochromic Compounds Having At Least Two Photochromic Moieties | CRY2, PCNA, MTCL3 | CYP3A4 3745/4885SMN1; SMN2 4493/4885NR1I2 4447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.